original ) (raw )Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Ab/ amyloid burden in a transgenic mouse model of Alzheimer's disease
Francesca Bosetti
J Neuroinflamm, 2010
View PDFchevron_right
Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease
Francesca Bosetti
Journal of Neuroinflammation, 2010
View PDFchevron_right
Therapeutic versus neuroinflammatory effects of passive immunization is dependent on A beta/amyloid
Francesca Bosetti
2010
View PDFchevron_right
An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
Dag Sehlin
Neurobiology of Disease, 2009
View PDFchevron_right
Amyloid-beta immunization in Alzheimer's disease transgenic mouse models and wildtype mice
Cynthia Lemere
Neurochemical research, 2003
View PDFchevron_right
Vaccination induced changes in pro-inflammatory cytokine levels as an early putative biomarker for cognitive improvement in a transgenic mouse model for Alzheimer disease
Xiaoyang Lin
Human vaccines & immunotherapeutics, 2014
View PDFchevron_right
The generation and characterization of potentially therapeutic Aβ antibodies in mice: differences according to strain and immunization protocol
Cynthia Lemere
Vaccine, 2002
View PDFchevron_right
Immunotherapeutic Strategies for Alzheimer's Disease Treatment
Beka Solomon
The Scientific World JOURNAL, 2009
View PDFchevron_right
‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches
Pierre-jean Ousset
Journal of Neurochemistry, 2012
View PDFchevron_right
Amelioration of amyloid load by anti-Aβ single-chain antibody in Alzheimer mouse model
Ken-ichiro Fukuchi
Biochemical and Biophysical Research Communications, 2006
View PDFchevron_right
Immunotherapy for Alzheimer's disease: attacking amyloid-â from the inside
Beka Solomon
Trends in Immunology, 2007
View PDFchevron_right
Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-í µí»½ Vaccine
Gjumrakch Aliev , Carmen Vigo
BioMed Research International
View PDFchevron_right
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
Thomas Wisniewski
Alzheimer's Research & Therapy, 2018
View PDFchevron_right
An Attenuated Immune Response Is Sufficient to Enhance Cognition in an Alzheimer's Disease Mouse Model Immunized with Amyloid-β Derivatives
Thomas Wisniewski
The Journal of Neuroscience, 2004
View PDFchevron_right
Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
Carmen Vigo
BioMed Research International, 2013
View PDFchevron_right
Immunological Approach for the Treatment of Alzheimer's Disease
Beka Solomon
Journal of Molecular Neuroscience, 2003
View PDFchevron_right
Immunotherapy for Alzheimer's disease: attacking amyloid-� from the inside
Beka Solomon
Trends Immunol, 2007
View PDFchevron_right
Novel Aβ peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease
Maria Isabel Burgos Fonseca
2005
View PDFchevron_right
Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go
Rommy von Bernhardi
View PDFchevron_right
An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-�� derivatives
Ayodeji Asuni
2004
View PDFchevron_right
A Vaccine Kit for Prevention and Therapy of Alzheimer’s Disease in a Transgenic Mouse Model
Ramón Cacabelos
Journal of Exploratory Research in Pharmacology
View PDFchevron_right
Immunotherapy for Alzheimer's disease: attacking amyloid-β from the inside
Beka Solomon
Trends in Immunology, 2007
View PDFchevron_right
Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased …
A. Rojiani
Journal of …, 2004
View PDFchevron_right
Immunization with a Nontoxic/Nonfibrillar Amyloid-β Homologous Peptide Reduces Alzheimer's Disease-Associated Pathology in Transgenic Mice
Thomas Wisniewski
The American Journal of Pathology, 2001
View PDFchevron_right
Immunotherapy in Alzheimer’s Disease: Do We Have All the Pieces of the Puzzle?
Pierre Aucouturier
Biological Psychiatry, 2013
View PDFchevron_right
Antibody therapy for Alzheimer's disease
Takeshi Tabira
Clinical Genetics, 1999
View PDFchevron_right
Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward
Andrea Santamato
Expert Review of Clinical Immunology, 2014
View PDFchevron_right
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
kim weiss
Nature Medicine, 2000
View PDFchevron_right
Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model
Chantal Mathis
Nature neuroscience, 2002
View PDFchevron_right
Immunization Therapy for Alzheimer Disease: A Comprehensive Review of Active Immunization Strategies
Takeshi Tabira
Tohoku Journal of Experimental Medicine, 2010
View PDFchevron_right
Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer’s disease
xing wei
Journal of Neurology Neurosurgery and Psychiatry, 2004
View PDFchevron_right
Alzheimer's Disease and Immune Response: A Brief Overview
Shailendra Kumar Mishra
Journal of Alzheimers Disease & Parkinsonism, 2017
View PDFchevron_right
Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease
Sandra Villegas
mAbs, 2013
View PDFchevron_right
A Comparative Evaluation of a Novel Vaccine in APP/PS1 Mouse Models of Alzheimer’s Disease
Madepalli Lakshmana , Carmen Vigo
BioMed Research International, 2015
View PDFchevron_right